CG Oncology Speeds Up PIVOT-006 Phase 3 Readout for Bladder Cancer—Data Now Expected in 1H 2026, Nearly a Year Early
Market Chameleon (Fri, 9-Jan 10:30 AM)
CG Oncology Accelerates PIVOT-006 Phase 3 Timeline: Topline Data for Intermediate-Risk NMIBC Expected Nearly a Year Early
Market Chameleon (Fri, 9-Jan 9:39 AM)
